show episodes
 
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork

1
Speaking of Mol Bio

Thermo Fisher Scientific

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, scien ...
  continue reading
 
Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com
  continue reading
 
Artwork

1
Translating Proteomics

Nautilus Biotechnology

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. Hosts Parag Mallick Ph.D. and Andreas Huhmer Ph.D. of Nautilus Biotechnology aim to share their perspectives on important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
  continue reading
 
Artwork

1
BioBiz Buzz

https://biobizbuzz.com/

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Artwork
 
The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj AI Research CEO Daniel Faggella and team interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise
  continue reading
 
Artwork

1
The Stack Overflow Podcast

The Stack Overflow Podcast

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
For more than a dozen years, the Stack Overflow Podcast has been exploring what it means to be a software developer and how the art and practice of programming is changing our world. From Rails to React, from Java to Node.js, join the Stack home team for conversations with fascinating guests to help you understand how technology is made and where it’s headed.
  continue reading
 
Artwork

1
Recovery Radio Network

Station Manager

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
The Recovery Radio Network brings you twelve step speakers and workshops designed for recovering individuals and the people who support them. The speakers share their personal experiences of recovery on the topics of alcoholism, co-dependency, and drug addiction, while our workshops are aimed at helping recovering individuals develop a better understand of twelve step programs.
  continue reading
 
Artwork
 
The clinical trials process is broken. It is unbelievably expensive and slow: it takes more than ten years and a billion dollars to get a typical drug approved. Join Ross Rheingans-Yoo on Development & Research—a new video series on fixing drug development, with new episodes on Tuesdays.
  continue reading
 
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MA ...
  continue reading
 
Artwork
 
The daily cybersecurity news and analysis industry leaders depend on. Published each weekday, the program also includes interviews with a wide spectrum of experts from industry, academia, and research organizations all over the world.
  continue reading
 
Artwork
 
The Life Sciences D’n’A podcast is hosted by AI and data analytics experts and pharma industry veterans Nagaraja Srivatsan and Amar Drawid. They explore the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
ACRO’s Good Clinical Podcast dives into topics vital to driving innovation in clinical research, from AI and other cutting-edge technology to regulatory topics that impact clinical trials around the world. ACRO's Sophia McLeod is joined by leaders from across the drug development industry to discuss the latest trends and what direction the industry must head to continue improving trials for patients
  continue reading
 
Artwork

1
Ask AI

Ask AI

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Curious about AI and the future of work? The Ask AI podcast delivers thought-proviking interviews and practical insights that help you spot the opportunities and navigate the challenges associated with the increased use of artificial intelligence at work. Episode Posts: https://www.askai.org/blog Show Producer: https://www.linkedin.com/in/mclellanchris/
  continue reading
 
Artwork

1
Decisions Now

Heartcast Media

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Decisions Now is a podcast presented by Evalueserve discussing how to generate decision-ready insights from artificial intelligence and data. In each episode, host Erin Pearson talks with experts, analysts, and business leaders across industries to bring you insights on diverse AI subjects. Subscribe today, and don’t miss an episode.
  continue reading
 
Artwork

1
Transformation in Trials

Sam Parnell & Ivanna Rosendal

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
A podcast about the transformations in clinical trial. As life science companies are pressured to deliver novel drugs faster, data, processes, applications, roles and change itself is changing. We speak to people in the industry that experience these transformations up close and make sense of how the pressure can become a catalyst for transformation.
  continue reading
 
A podcast on statistical science and clinical trials. Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to pro ...
  continue reading
 
Artwork
 
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
  continue reading
 
Artwork

1
PharmaTalkRadio

Pharma Talk Radio

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership ...
  continue reading
 
Artwork

1
RARECast

RARECast

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
  continue reading
 
Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to li ...
  continue reading
 
Artwork

1
The Heart & Science of Leadership

Dr. Paul "Paulie" Gavoni

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
The Heart & Science of Leadership" podcast, co-hosted by Dr. Paulie and A.J. Rinaldi, combines their diverse backgrounds in leadership to offer a comprehensive view on what it takes to lead effectively, no matter your position—be it executive, teacher, manager, principal, supervisor, or coach. Together, they explore the balance between the human side of leadership and evidence-based practices, providing listeners with practical tools, real-life stories, and actionable strategies. Whether you ...
  continue reading
 
Artwork

1
FDA Watch

FDA Watch

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
FDA Watch is a twice-monthly, national podcast that provides an independent, non-partisan forum for discussing and understanding the latest developments, trends, and issues involving FDA. The podcast focuses on four core areas: pharmaceuticals and biologics; medical devices and diagnostics; food and dietary supplements; and cosmetics and personal care products, as well as on the overall direction of FDA regulation. The podcast also will have bonus episodes to cover breaking news. Podcast gue ...
  continue reading
 
Artwork

1
CMC Live - Chemistry, Manufacturing & Controls

Meranda Parascandola, Ed Narke

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
FDA CMC regulations and guidance simplified through examination, real life experiences and risk-based advice. This podcast hopes to educate sponsors and individuals on agency related regulatory CMC matters. We will focus on the critical CMC issues and build programs that enhance drug development. CMC topics will include Regulatory Starting Materials, API and Drug Product Process, Formulation Development, Supply Chains, Analytical Controls. Advocating and interpreting CMC Strategy, directing ...
  continue reading
 
Artwork

1
Med X Health

MedX Health

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
This podcast discusses MedX Health, listed on the TSX-V under the symbol MDX, whose mission is to develop and implement non-invasive, practical, drug-free and cost-effective skin analysis and assessment systems for use by trained medical professionals, as well as light therapeutics and imaging systems that can help to save lives and enhance patients’ quality of life and improve standards of care.
  continue reading
 
Artwork
 
Every Wednesday, join Rick Barron as he unravels the intricate threads of life's most captivating stories. From heart-pounding political dramas to the awe-inspiring challenges of climate change, he explores the topics that shape our world and define our era. But this isn't just another talk show. Rick delves deep into the human psyche, examining our beliefs, behaviors, and the obstacles we overcome. He celebrates our triumphs and embraces our imperfections, uncovering the profound lessons hi ...
  continue reading
 
Artwork

1
Laborastories | presented by ADLM

Association for Diagnostics & Laboratory Medicine (formerly AACC)

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
ADLM is pleased to present Laborastories: The Podcast. In this new series, ADLM President Dr. Anthony Killeen talks with experts in laboratory medicine to learn more about the people behind clinical laboratory testing and explore both the current issues they are facing and the many ways their work impacts patient lives. Remember – every laboratorian has a story.
  continue reading
 
Artwork
 
Discoveries in technology, medicine, and nutrition are emerging with accelerating speed and improving our health and quality of life. Brought to you by Lonza, “A View On” podcast is a series of short conversations with industry leaders. Join us to discuss new trends that are impacting scientific research, drug discovery and business. The series of monthly conversations with pharma, biotech and nutrition leaders from across industry and academia covers a wide range of topics from 3D bioprinti ...
  continue reading
 
Loading …
show series
 
Venky Iyer, director of data strategy and automation at Pfizer, sits down with Nagaraja Srivatsan to discuss the transformative role of AI and machine learning in the pharmaceutical industry. They discuss Iyer’s journey in implementing AI solutions to enhance operational efficiency at Pfizer. They talk about the importance of engaging operational t…
  continue reading
 
The Children’s Tumor Foundation has been effective in working with drug developers to advance new therapies for neurofibromatosis, a group of rare, genetic conditions that cause tumors to grow on nerves throughout the body. Part of its success has been its ability to get biopharmaceutical companies to reposition assets once in development for other…
  continue reading
 
Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years of experience applying AI, machine learning, and real-world data to drug development and precision medicine, Damion joins Emerj Managing Editor Matthew DeMello to explore the evolving role of AI in drug development and supply chain management. He breaks…
  continue reading
 
In this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdles and everything in between. Drawing on decades of experience, they share personal stories and expert insights that reveal why a solid strategy and the ability to pivot are essential for success. The…
  continue reading
 
More and more, artificial intelligence is becoming inseparable from drug development. But it needs to be well integrated with the right people and support technologies in order to be successful, according to Josep Bassaganya-Riera, the founder and CEO of Nimmune Biopharma Inc. Nimmune has leveraged methods of AI-enabled drug discovery to develop a …
  continue reading
 
In this engaging episode of "In the Interim...", host Dr. Scott Berry is joined by Dr. Nick Berry to explore the intriguing statistical parallels between sports and drug development, focusing on the concept of "regression-to-the-mean." Presenting examples that seem clear in sports, they discuss how these insights can illuminate the challenges faced…
  continue reading
 
A House oversight committee requests DOGE documents from Microsoft. Predatory Sparrow claims a cyberattack on an Iranian bank. Microsoft says data that happens in Europe will stay in Europe. A complex malware campaign is using heavily obfuscated Visual Basic files to deploy RATs. A widely used CMS platform suffers potential RCE bugs. North Korea’s …
  continue reading
 
Greenpeace, the legendary environmental group that fought to save the whales, now finds itself fighting for survival. Supporting links 1. Greenpeace [Wikipedia] 2. Greenpeace [USA website] 3. Greenpeace International [YouTube] 4. The bombing of the Rainbow Warrior [Greenpeace website] Contact That's Life, I Swear Visit my website: https://www.thats…
  continue reading
 
Today’s guest is Yunke Xiang, Global Head of Data Science for Manufacturing, Supply Chain, and Quality at Sanofi. Yunke joins Emerj Editorial Director Matthew DeMello to discuss the challenges that slow AI adoption in life sciences manufacturing, highlighting how fragmented data systems and legacy infrastructure create hurdles for AI initiatives. I…
  continue reading
 
Max Marchione, Co-Founder of Superpower, discusses his experience founding a health tech company, making concierge medicine accessible to all, and the future of healthcare. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a f…
  continue reading
 
International law enforcement takes down a darknet drug marketplace. The Washington Post is investigating a cyberattack targeting several journalists' email accounts. Anubis ransomware adds destructive capabilities. The GrayAlpha threat group uses fake browser update pages to deliver advanced malware. Researchers uncover a stealthy malware campaign…
  continue reading
 
In 2024, ACRO announced its D&I Site Resource Grants Program. Designed to support an innovative 12-month pilot project, the site resource grants act as a platform to incubate innovative strategies for improving representative enrollment in clinical research. On this episode, site grantee representatives Dr. Ammara Mushtaq, MD (Brooklyn Clinical Res…
  continue reading
 
“We want to create differences between cancer and non-cancer cells that we can exploit with therapy. And what's elegant about this [nutritional] approach is that we're able to use drugs that are otherwise very blunt instruments in the treatment of cancer.” —Peter Attia The post #353 – AMA #72: Fasting: benefits for body composition and disease prev…
  continue reading
 
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter revisits the topic of fasting, sharing how his thinking has evolved over time. The episode explores fasting-related terminology and common types of fasting, as well as the…
  continue reading
 
Please enjoy this encore of Career Notes. Distinguished Cloud Strategist at Lacework, Mark Nunnikhoven, has gone from taking technology to its limits for his own understanding to providing clarity about security for others. Mark fell in love with his Commodore 128 and once he realized he could bend the machine to his will, it set him on the path to…
  continue reading
 
This week, Dave is joined by ⁠Ziv Karliner⁠, ⁠Pillar Security⁠’s Co-Founder and CTO, sharing details on their work on "New Vulnerability in GitHub Copilot and Cursor: How Hackers Can Weaponize Code Agents." Vibe Coding - where developers use AI assistants like GitHub Copilot and Cursor to generate code almost instantly - has become central to how e…
  continue reading
 
Cloudflare says yesterday’s widespread outage was not caused by a cyberattack. Predator mobile spyware remains highly active. Microsoft is investigating ongoing Microsoft 365 authentication services issues. An account takeover campaign targets Entra ID users by abusing a popular pen testing tool. Palo Alto Networks documents a JavaScript obfuscatio…
  continue reading
 
Together AI is a platform for building with open-source and specialized multimodal models. Check out their docs. Connect with Jamie on LinkedIn. Shoutout to user aryaxt who earned a Stellar Question badge by wondering about MySQL Data - Best way to implement paging?.By Ryan Donovan, Ben, Jamie de Guerre
  continue reading
 
In this episode of Decisions Now, host Erin Pearson speaks with Aleksandar Ruzic about how value-based healthcare, patient-centric design, and data science are reshaping commercial strategies in life sciences. Aleks shares powerful real-world examples from rare diseases, obesity treatments, and global market launches, revealing how integrating valu…
  continue reading
 
Interpol’s Operation Secure dismantles a major cybercrime network, and Singapore takes down scam centers. GitLab patches multiple vulnerabilities in its DevSecOps platform. Researchers unveil a covert method for exfiltrating data using smartwatches. EchoLeak allows for data exfiltration from Microsoft Copilot. Journalists are confirmed targets of P…
  continue reading
 
This week on The Pharma Letter Podcast, we’re joined by Howard Fillit, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation (ADDF). As the FDA approval of anti-amyloid drugs like lecanemab and donanemab marks a new era in the treatment of Alzheimer’s, questions remain around cost, access, and real-world impact. A geriat…
  continue reading
 
In a medical first, a team at Children’s Hospital of Philadelphia and Penn Medicine has successfully treated an infant diagnosed with a rare genetic disorder by using a customized CRISPR gene editing therapy. The work, led by Penn Medicine’s Kiran Musunuru and CHOP’s Rebecca Ahrens-Nicklas, points to the potential to use bespoke gene editing therap…
  continue reading
 
Today’s guest is Tim Burge, Director at Aquant. Aquant is an AI platform built for service teams that maintain and repair complex equipment. It gives clear, accurate answers to service questions — from basic fixes to deep diagnostics — so field techs, call centers, managers, and customers can get to solutions faster. Used by top manufacturers like …
  continue reading
 
In this episode of the ‘AI in Business’ podcast, Principal Group Product Manager Will Guyman of Microsoft and Senior Director Lyndi Wu of NVIDIA explore how healthcare providers are deploying AI at scale to drive clinical and operational transformation. With host Matthew DeMello, they discuss the combined power of NVIDIA’s GPU acceleration and Micr…
  continue reading
 
Register for Free, Live webcasts & summits: https://poweredbybhis.com 00:00 - PreShow Banter™ — Time to Bake 05:12 - Chatbot Tells Addict to Take Drugs - Talkin’ Bout [infosec] News 2025-05-06 06:08 - Story # 1: Meta and Yandex are de-anonymizing Android users’ web browsing identifiers 12:55 - Story # 2: Therapy Chatbot Tells Recovering Addict to H…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play